Literature DB >> 24960640

Variants of CD36 gene and their association with CD36 protein expression in platelets.

Xianguo Xu1, Ying Liu1, Xiaozhen Hong1, Shu Chen1, Kairong Ma1, Xiaofei Lan1, Yanling Ying1, Ji He1, Faming Zhu1, Hangjun Lv1.   

Abstract

BACKGROUND: The relationship between CD36 expression level in platelets and polymorphism of the CD36 gene still needs to be explored. Here, we investigated polymorphisms of the CD36 gene and CD36 expression level in platelets in the Chinese Han population.
MATERIALS AND METHODS: A total of 477 samples were sequenced for exons 2 to 14 of the CD36 gene using a polymerase chain reaction sequence-based typing method. In 192 of these individuals the expression levels of CD36 antigen were analysed by flow cytometry. The genotype-phenotype relationship in platelets was analysed.
RESULTS: A total of 22 variants of the CD36 gene were identified, of which five variants (111 A>T, 681 C>A, 1172-1183 del12b, 1236 delT and 1395 A>C) were novel variations, and nine were also found in single nucleotide polymorphism database (dbSNP) but had not been confirmed in individuals with CD36 deficiency. Two variants (329-332 delAC and 1228-1239 del12bp) in the coding region are the most frequent mutations in the Chinese population. Type II CD36 deficiency was identified in seven of 192 individuals, giving a frequency of 3.6%. Individuals with CD36 variations or wild-type genotypes both showed CD36 antigen negative, low-level and high-level expression patterns in platelets. The frequency of the nt-132 A>C polymorphism in the 5'-UTR is relatively high in the Chinese population (0.3516): the expression of CD36 was lower in individuals with nt-132 A>C than in those with the wild-type genotype. DISCUSSION: The distribution of CD36 gene variants in the Chinese population is different from that previously reported. The levels of expression of CD36 antigen in platelets are not determined directly by the genotypes of the CD36 coding region. This suggests that the molecular basis of type II CD36 deficiency may be derived from combined effects of coding region and potential cis-regulatory elements in the 5'-UTR of the CD36 gene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24960640      PMCID: PMC4212037          DOI: 10.2450/2014.0209-13

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  25 in total

1.  Identification of cryptic splice site, exon skipping, and novel point mutations in type I CD36 deficiency.

Authors:  H Hanawa; K Watanabe; T Nakamura; Y Ogawa; K Toba; I Fuse; M Kodama; K Kato; K Fuse; Y Aizawa
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

Review 2.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

Authors:  M Febbraio; D P Hajjar; R L Silverstein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Variability of the CD36 gene in West Africa.

Authors:  A Gelhaus; A Scheding; E Browne; G D Burchard; R D Horstmann
Journal:  Hum Mutat       Date:  2001-11       Impact factor: 4.878

4.  Prevalence of the HPA-18w to -21w alleles in the Chinese Han population.

Authors:  Y Liu; X Hong; X Xu; Y Ying; J He; F Zhu; H Lv; L Yan
Journal:  Int J Immunogenet       Date:  2012-08-04       Impact factor: 1.466

5.  Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion.

Authors:  N N Tandon; U Kralisz; G A Jamieson
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

6.  Genomic heterogeneity of type II CD36 deficiency.

Authors:  Makoto Imai; Takao Tanaka; Taigo Kintaka; Toshiyuki Ikemoto; Akira Shimizu; Yasushi Kitaura
Journal:  Clin Chim Acta       Date:  2002-07       Impact factor: 3.786

Review 7.  Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis.

Authors:  A C Nicholson; J Han; M Febbraio; R L Silversterin; D P Hajjar
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

8.  Analyses of genetic abnormalities in type I CD36 deficiency in Japan: identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man.

Authors:  H Kashiwagi; Y Tomiyama; S Nozaki; T Kiyoi; S Tadokoro; K Matsumoto; S Honda; S Kosugi; Y Kurata; Y Matsuzawa
Journal:  Hum Genet       Date:  2001-06       Impact factor: 4.132

9.  Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol.

Authors:  H Yanai; H Chiba; M Morimoto; K Abe; H Fujiwara; H Fuda; S P Hui; Y Takahashi; H Akita; G A Jamieson; K Kobayashi; K Matsuno
Journal:  Am J Med Genet       Date:  2000-08-14

10.  Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV.

Authors:  Y Tomiyama; H Take; H Ikeda; T Mitani; T Furubayashi; H Mizutani; N Yamamoto; N N Tandon; S Sekiguchi; G A Jamieson
Journal:  Blood       Date:  1990-02-01       Impact factor: 22.113

View more
  1 in total

1.  Functionalization of CD36 cardiovascular disease and expression associated variants by interdisciplinary high throughput analysis.

Authors:  Namrata Madan; Andrew R Ghazi; Xianguo Kong; Edward S Chen; Chad A Shaw; Leonard C Edelstein
Journal:  PLoS Genet       Date:  2019-07-25       Impact factor: 5.917

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.